In considering the grounds on which to award patents for applications of germline gene therapy, the European Patent Office may have to decide on the basis of "morality". This should not be its job.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Price, R., Cohen, S. A moral question for patent legislation. Nature 369, 589 (1994). https://doi.org/10.1038/369589a0
Issue Date:
DOI: https://doi.org/10.1038/369589a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.